pemphigu
vulgari
pv
rare
highli
disabl
untreat
almost
alway
fatal
immunobul
diseas
skin
mucou
membran
pv
character
histolog
loss
cellcel
adhes
suprabas
keratinocyt
lead
acantholysi
immunopatholog
presenc
circul
tissuebound
autoantibodi
autoab
keratinocyt
cell
surfac
antigen
specif
desmoglein
dsg
pv
consid
paradigmat
organspecif
autoimmun
diseas
view
present
knowledg
diseas
autoantigen
pathogenesi
ii
reproduc
major
clinic
pathogen
featur
anim
model
exist
pathogen
nonpathogen
antidsg
autoab
recent
underscor
isol
human
monoclon
antibodi
hmab
pemphigu
patient
antidsg
hmab
character
shown
pathogen
potenti
primarili
depend
target
epitop
interest
character
repertoir
natur
occur
autoreact
epitheliumspecif
memori
b
cell
pemphigu
vulgari
patient
first
work
focus
autoantibodi
target
howev
lack
tight
correl
antidsg
autoab
titer
diseas
activ
patient
ii
signific
degre
diseas
heterogen
point
import
nondsg
autoab
progress
even
though
exhaust
describ
fact
besid
nondesmoglein
autoab
either
pathogen
nonpathogen
identifi
pemphigu
patient
autoab
endow
acantholyt
potenti
target
desmocollin
receptor
pemphaxin
keratinocyt
mitochondria
hand
pathogen
role
autoab
recogn
autoantigen
desmocollin
periplakin
ecadherin
desmoglein
desmoplakin
desmoplakin
remain
demonstr
line
interest
current
work
aim
identifi
autoab
target
nondsg
membranebound
membraneassoci
intracellular
antigen
present
studi
report
character
hmab
isol
pv
patient
direct
novel
nondsg
antigen
hmab
react
recogn
almost
half
pv
sera
analyz
peripher
blood
obtain
patient
pvc
pvf
suffer
activ
mucocutan
pv
patient
show
typic
clinic
histolog
immunopatholog
featur
hightit
antidsg
circul
autoantibodi
pvc
uml
uml
pvf
uml
uml
assess
elisa
kit
base
ectodomain
mbl
nagoya
japan
hmab
isol
highlyeffici
protocol
immort
igg
memori
b
cell
epstein
barr
viru
ebv
presenc
tolllik
receptor
agonist
previous
describ
detail
igg
memori
b
cell
isol
cryopreserv
peripher
blood
mononuclear
cell
use
microbead
miltenyi
biotec
bo
itali
follow
deplet
cell
carri
igm
igd
iga
cell
sort
multipl
replic
microcultur
igg
memori
b
cellswel
total
purifi
cell
infect
ebv
cpg
previous
describ
cultur
supernat
test
bind
elisa
plate
bind
hacat
keratinocyt
cell
line
monolay
live
cell
fix
permeabil
cell
immunofluoresc
assay
use
autom
fluoresc
microscop
pathway
bd
specif
posit
polyclon
cultur
assess
primari
human
keratinocyt
posit
reactiv
confirm
propag
oligoclon
cultur
posit
cultur
clone
limit
dilut
expand
antibodi
purifi
use
protein
g
column
serum
sampl
collect
pv
bullou
pemphigoid
bp
patient
healthi
donor
studi
carri
conform
helsinki
guidelin
approv
idiircc
ethic
committe
biolog
sampl
obtain
patient
inform
consent
studi
perform
accord
procedur
describ
di
zenzo
et
al
minor
modif
briefli
supernat
immort
human
memori
b
cell
screen
monolay
live
fixedpermeabil
hacat
cell
wash
phosphatebuff
salin
cell
stain
alexa
fluor
goat
antihuman
igg
invitrogen
carlsbad
ca
usa
isol
monoclon
antibodi
test
permeabil
hacat
cell
primari
keratinocyt
nonkeratinocyt
cell
line
ie
hela
skmel
cell
use
control
analys
cell
monolay
human
antibodi
irrelev
specif
use
neg
control
serial
imag
stain
keratinocyt
monolay
acquir
bd
pathway
autom
fluoresc
microscop
stain
also
perform
cryo
section
normal
human
skin
guinea
pig
monkey
esophagu
reveal
fluorescein
isothiocyanateconjug
antihuman
igg
antibodi
agil
dako
santa
clara
ca
usa
immunoprecipit
ip
keratinocyt
extract
hmab
carri
previous
describ
precipit
protein
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
gel
reduc
condit
detect
autoradiographi
immunoblot
ib
experi
keratinocyt
extract
perform
previous
report
use
horseradish
peroxidas
hrp
conjug
alkalin
phosphataseconjug
secondari
antibodi
band
quantifi
use
imagej
softwar
nation
institut
health
bethesda
md
usa
intens
normal
respect
posit
control
signal
obtain
antibodi
cutoff
valu
set
medium
valu
standard
deviat
obtain
measur
signal
obtain
healthi
donor
commerci
primari
antibodi
purchas
progen
biotechnik
gmbh
heidelberg
germani
antidesmocollin
bd
bioscienc
san
jose
ca
usa
santa
cruz
biotechnolog
inc
dalla
tx
usa
antiecadherin
recombin
tag
human
purchas
abcam
cambridg
uk
rule
pv
sera
mainli
react
fuse
glutathion
stransferas
gst
moieti
recombin
protein
ib
experi
use
commerci
tag
protein
equimolar
gst
perform
data
shown
briefli
recombin
ectodomain
produc
baculoviru
use
coat
elisa
plate
plate
block
bovin
serum
albumin
incub
antibodi
follow
hrpconjug
antihuman
igg
jackson
immunoresearch
baltimor
pa
usa
assay
perform
previous
report
briefli
primari
human
keratinocyt
cell
seed
onto
plate
h
postconflu
treat
monoclon
antibodi
ad
exfoli
toxin
cleav
protein
cell
monolay
detach
dispas
merck
kgaa
darmstadt
germani
subject
mechan
stress
pipet
monolay
fragment
fix
ad
formaldehyd
solut
subsequ
stain
use
crystal
violet
investig
possibl
synergist
effect
appli
monolay
togeth
pathogen
antibodi
optim
suboptim
concentr
figur
nonpathogen
antibodi
germlin
version
abl
dissoci
keratinocyt
monolay
data
shown
order
identifi
hmab
target
nondsg
membranebound
membraneassoci
intracellular
antigen
took
advantag
strategi
previous
isol
fine
character
sever
dsgreactiv
pv
patientderiv
monoclon
autoantibodi
detail
peripher
blood
sampl
collect
patient
mucocutan
pv
one
longlast
steroidresist
diseas
pvc
prior
treatment
initi
pvf
igg
memori
b
cell
isol
magnet
fluorescenceactiv
cell
sort
seed
micropl
immort
ebv
presenc
irradi
mononuclear
cell
oligodeoxynucleotid
contain
cpg
motif
previous
describ
reactiv
antibodi
secret
supernat
grow
polyclon
cultur
screen
stain
live
fix
permeabil
cell
human
keratinocyt
hacat
cell
line
polyclon
antibodi
produc
vast
major
isol
cultur
bound
surfac
antigen
keratinocyt
membran
reactiv
andor
ectodomain
elisa
previous
report
data
shown
besid
preval
pattern
reactiv
supernat
rare
cultur
patient
show
distinct
membraneassoci
fishnet
reactiv
detect
permeabil
keratinocyt
neg
elisa
ectodomain
human
mab
isotyp
clone
limit
dilut
show
pattern
origin
polyclon
cultur
also
permeabil
hacat
keratinocyt
figur
suggest
specif
membraneassoci
intracellular
ie
nonexpos
autoantigen
addit
show
intercellular
stain
pattern
human
skin
guinea
pig
monkey
esophagu
figur
similar
stain
pattern
antibodi
data
shown
supernat
select
clone
test
nonkeratinocyt
cell
line
ie
fibroblast
skmel
melanoma
hela
epitheli
cell
fail
stain
live
permeabil
cell
apart
reactiv
permeabil
hela
cell
data
shown
hint
specif
membraneassoci
intracellular
antigen
express
keratinocyt
epitheli
cell
ip
studi
select
clone
radiolabel
keratinocyt
extract
identifi
target
antigen
show
reactiv
kda
antigen
figur
kda
antigen
respect
data
shown
ip
result
latter
two
clone
point
member
plakinfamili
candid
target
antigen
autoreact
pv
sera
plakin
famili
member
alreadi
document
chose
character
aim
identifi
possibl
novel
membraneassoci
pv
autoantigen
subsequ
ib
experi
use
commerci
antibodi
react
keratinocyt
membraneassoci
protein
molecular
weight
kda
desmocollin
kda
kda
kda
kda
kda
kda
indic
put
antigen
figur
sequenti
ip
ib
experi
support
target
antigen
specif
protein
immunoprecipit
keratinocyt
extract
recogn
commerci
antibodi
antibodi
turn
abl
immunoprecipit
protein
recogn
ib
figur
final
ib
experi
recombin
tag
protein
unequivoc
confirm
specif
bind
figur
determin
whether
autoab
specif
present
sera
pv
patient
perform
ib
experi
pv
sera
recombin
tag
figur
four
pv
patient
show
reactiv
wherea
pv
sera
normal
human
control
sera
show
faint
signal
indic
autoreact
wellrepres
pv
patient
even
though
share
patient
order
evalu
whether
reactiv
diseasespecif
bp
patient
sera
analyz
recombin
ib
one
bp
repres
bp
sera
shown
shown
react
supplementari
figur
underlin
specif
autoantigen
weak
signal
found
remain
pv
pb
healthi
donor
sera
might
ascrib
reactiv
tag
protein
gst
presenc
autoab
sever
pv
sera
rais
question
pathogen
potenti
previou
studi
show
abil
intact
autoab
enter
cytosol
nucleu
live
cell
recent
marchenko
et
al
report
pv
autoab
could
penetr
keratinocyt
react
intracellular
mitochondri
protein
find
suggest
hmab
intracellular
antigen
could
exert
pathogen
abil
live
keratinocyt
thu
vitro
dissoci
assay
use
evalu
pathogen
activ
hmab
approach
allow
measur
abil
specif
antibodi
mixtur
antibodi
serum
fragment
monolay
primari
human
keratinocyt
seed
confluenc
keratinocyt
monolay
incub
h
remain
intact
similarli
monolay
incub
unrel
hmab
use
neg
control
figur
expect
human
murin
pathogen
antibodi
abl
dissoci
monolay
figur
addit
fail
synerg
pathogen
antibodi
figur
find
exclud
primari
pathogen
function
autoab
pv
nevertheless
potenti
secondari
role
immunobiolog
diseas
exclud
warrant
futur
studi
present
work
went
forward
character
divers
target
epitheliumspecif
autoreact
b
cell
pv
patient
purpos
took
advantag
higheffici
immort
protocol
igg
memori
b
cell
previous
develop
appli
isol
molecularli
character
number
hmab
present
focu
detect
plasmamembraneassoci
antigen
either
express
cell
surfac
intracellularli
therefor
chose
screen
isol
polyclon
cultur
live
permeabil
keratinocyt
choic
base
hypothesi
antigen
associ
cell
membran
even
intracellular
local
could
higher
chanc
contribut
pemphigu
pathogenesi
due
loss
cellcel
adhes
expect
vast
major
cultur
result
specif
andor
confirm
major
role
antigen
pemphigu
pathogenesi
among
polyclon
cultur
react
permeabil
keratinocyt
select
clone
give
membraneassoci
fishnetlik
stain
pattern
stratifi
epithelia
among
clone
cultur
character
clone
demonstr
ip
ib
studi
target
compon
adheren
junction
aj
ie
cellcel
anchor
structur
togeth
desmosom
allow
keratinocyt
adher
one
anoth
maintain
epitheli
integr
bind
aj
requir
format
mainten
addit
report
necessari
organ
desmosom
epitheli
cell
previou
studi
report
reactiv
pemphigu
sera
anoth
aj
compon
ie
ecadherin
likewis
show
autoreact
wellrepres
pv
patient
sera
recogn
almost
half
pv
sera
test
ii
frequent
associ
pemphigu
autoimmun
bullou
diseas
rare
recogn
bp
sera
analyz
consid
previou
studi
demonstr
abil
intact
autoab
enter
live
cell
address
potenti
pathogen
mab
evalu
acantholyt
activ
vitro
keratinocyt
dissoci
assay
regard
sever
observ
suggest
aj
particular
ecadherin
may
involv
pemphigu
pathogenesi
note
except
antidesmocollin
autoab
known
nondsgreact
autoab
report
pathogen
possess
acantholyt
potenti
may
act
synergist
antidsg
antibodi
accordingli
marchenko
et
al
describ
pathogen
role
intracellular
antimitochondri
autoab
even
though
hand
mab
abl
dissoci
keratinocyt
monolay
either
alon
combin
suboptim
dose
pathogen
antibodi
nevertheless
exclud
region
differ
recogn
could
recogn
pv
sera
contribut
acantholysi
addit
possibl
role
hmab
cofactor
diseas
initi
mainten
could
exhaust
address
approach
previou
studi
sever
antibodi
intracellular
antigen
consid
trigger
autoimmun
mab
specif
cytoplasm
precursor
form
clone
pemphigu
patient
healthi
individu
yamagami
et
al
postul
presenc
b
cell
involv
initi
autoimmun
respons
pemphigu
patient
particular
context
tissu
damag
could
present
peptid
part
matur
ie
extracellular
autoantigen
recogn
pathogenet
autoab
deriv
process
intramolecular
epitop
spread
phenomenon
could
lead
product
pathogen
autoab
target
matur
initi
diseas
pathogenesi
moreov
natur
autoab
naa
ie
antibodi
intracellular
autoantigen
natur
occur
healthi
popul
per
se
unabl
caus
immun
phatolog
theoriz
cofactor
onset
autoimmun
possibl
particip
mechan
chronic
tissu
injuri
basi
intermolecular
epitop
spread
conclus
previou
studi
demonstr
pathogen
pv
antibodi
primarili
target
cisinterfac
thu
lead
desmosom
disrupt
current
result
reveal
novel
antibodi
target
intracellular
keratinocyt
protein
tempt
specul
cellular
damag
induc
pathogen
antidsg
antibodi
may
trigger
intermolecular
epitopespread
phenomenon
result
antibodi
respons
intracellular
antigen
among
studi
need
evalu
whether
may
act
synergist
antidsg
antibodi
use
inform
approach
vitro
organ
cultur
vivo
model
ii
assess
possibl
role
autoab
pemphigu
initi
evolut
vivo
iii
character
novel
antigen
possibl
target
epitop
spread
phenomena
pv
dataset
gener
studi
avail
request
correspond
author
studi
carri
accord
recommend
helsinki
guidelin
idiircc
ethic
committe
protocol
approv
idiircc
ethic
committe
subject
gave
written
inform
consent
accord
declar
helsinki
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
